Find new channel for overcoming chemoresistance in cancers: Role of stem cells-derived exosomal microRNAs

Int J Biol Macromol. 2022 Oct 31:219:530-537. doi: 10.1016/j.ijbiomac.2022.07.253. Epub 2022 Aug 7.

Abstract

Chemoresistance has remained a significant concern in tumor recurrence and elevated cancer-related mortalities. A deep insight into mechanisms by which cancerous cells resist administered drugs can pave the way to overcome chemotherapy-induced cell death and develop novel procedures to rescue patients. Regarding accumulated data, stem cell-derived exosomal microRNAs (miRNAs) can be deemed a novel and promising method to overcome chemoresistance. It seems exosomal miRNAs play a dual role in the cancer microenvironment. On the one hand, as a messenger, they are transferred between donor and recipient cells contributing to cancer chemoresistance. On the other hand, stem cell-derived exosomal miRNA significantly restrains tumorigenesis and inhibits or alleviates drug resistance in the tumor niche. Hence, our purpose in this review evaluating the roles of stem cells-derived exosomal microRNAs in overcoming chemoresistance in tumors.

Keywords: Cancer; Chemoresistance; Exosomal microRNAs; Exosomes; microRNAs.

Publication types

  • Review

MeSH terms

  • Antineoplastic Agents* / metabolism
  • Antineoplastic Agents* / pharmacology
  • Antineoplastic Agents* / therapeutic use
  • Drug Resistance, Neoplasm / genetics
  • Exosomes* / genetics
  • Exosomes* / metabolism
  • Humans
  • MicroRNAs* / genetics
  • MicroRNAs* / metabolism
  • Neoplasms* / drug therapy
  • Neoplasms* / genetics
  • Neoplasms* / metabolism
  • Stem Cells / metabolism
  • Tumor Microenvironment / genetics

Substances

  • Antineoplastic Agents
  • MicroRNAs